A5059837490- Neutropenia and Cancer Infections
- Hematopoietic Stem Cell Transplantation
- Antibiotics Pharmacokinetics and Efficacy
- Hemoglobinopathies and Related Disorders
- Venous Thromboembolism Diagnosis and Management
- Chemical Safety and Risk Management
- Palliative Care and End-of-Life Issues
- Cancer Treatment and Pharmacology
- Anesthesia and Pain Management
- Blood Coagulation and Thrombosis Mechanisms
- Atrial Fibrillation Management and Outcomes
- Advanced Radiotherapy Techniques
- Safe Handling of Antineoplastic Drugs
- Polyomavirus and related diseases
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Erythropoietin and Anemia Treatment
- Iron Metabolism and Disorders
- Medical Device Sterilization and Disinfection
- Neonatal Respiratory Health Research
- Nausea and vomiting management
Prince of Songkla University
2015-2024
Although anti-thymocyte globulin with cyclosporine (rATG/CsA), bone marrow transplantation, and eltrombopag are the cornerstone treatment for severe very aplastic anemia (SAA/vSAA), oxymetholone remains beneficial in ineligible patients.This study was conducted to compare realistic effectiveness of rATG/CsA SAA/vSAA.The primary outcome 2-year overall response rate (ORR).Factors associated ORR were evaluated using a logistic model.The secondary outcomes 3-, 6-, 12-and 18-month survival...
PURPOSE To evaluate anticoagulant trends and clinical outcomes in the management of cancer-associated thrombosis (CAT) within Thailand, an upper-middle–income country (UMIC). METHODS This multicenter retrospective cohort study included adult patients with cancer diagnosed venous thromboembolism (VTE) hospitalized Thailand from 2017 to 2021. Anticoagulants were classified as low-molecular-weight heparin (LMWH), direct oral anticoagulants (DOACs), warfarin. Prescription assessed, followed for...
Purpose: This study evaluated factors that affect granulocyte-colony stimulating factor (G-CSF) adsorption in the infusion tube by measuring G-CSF concentration, rate of infusion, and volume flush solution. Methods: The concentrations all samples were measured an enzyme-linked immunosorbent assay (ELISA) using human Quantikine® ELISA kits. concentration G-CSF, administration, solution studied respectively. administration had a significantly lower percent recovery after via set used for...
Purpose: This work aimed at evaluating the impact of different concentrations and final volumes on compatibility physical properties dexamethasone-ondansetron intravenous (IV) admixture. Methods: The IV admixture was prepared using normal saline solution as solvent. volume 50 100 ml. Turbidity measured an indicator UV-visible spectrophotometer pH day 0, 7,14, and, 21 index chemical stability. Also, particle size potential molecular interactions admixtures were determined analyzer Fourier...
This studycompared thecontamination of the chemotherapeutic agent cyclophosphamide between using a conventional admixing procedure and closed system transfer devices (CSTDs). Surface wipes urine samples were collected for two weeks before after CSTDs used. The surface wipe from critical areas in an aseptic dispensary unit chemotherapy patient care unit. healthcare workers. Contamination was detected fewer following implementation CSTDs. mediancyclophospha-mide concentration usage...